RFA-HL-23-011 - Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice of Application Due Date Changes for RFA-HL-23-011,"Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)" NOT-HL-22-016 NHLBI Mar 24, 2022 Apr 19, 2026 R61/R33

For technical issues E-mail OER Webmaster